Benzinga's Top Upgrades (GSK, SI, VE, CM)

GlaxoSmithKline Plc GSK was upgraded by BofA/Merrill from “neutral” to "buy." GSK’s shares closed at $39.29 on Friday. GlaxoSmithKline’s trailing-twelve-month gross margin is 74.31%. UBS upgraded Siemens AG SI from “neutral” to "buy." SI’s shares closed at $96.43 on Friday. Siemens’ earnings may rise by 36.36% this year. Citigroup upgraded Veolia Environnement VE from “sell” to "buy.” VE’s shares closed at $24.93 on Friday. Veolia Environnement’s earnings are likely to increase by 131.02% this year. Analysts at RBC Capital upgraded Canadian Imperial Bank of Commerce CM from "sector perform" to "outperform." CM’s shares closed at $71.32 on Friday. CM’s quarterly earnings surged 50.53% y/y. More Analyst Ratings here